Even cities have their own unique microbiomes
A study of microorganisms collected from public transportation systems shows even cities have microbial signatures
After decades of work, an effective cytomegalovirus vaccine is on the horizon
Monoclonal antibodies reveal key vaccine structure
Releasing bacteria-infected mosquitoes in Indonesia prevented the spread of dengue
Mosquitos carrying Wolbachia pipientis bacteria don't spread dengue fever
New study finds people with COVID-19 have antibodies that target their own immune systems
Autoantibodies hamper the immune system from fighting the virus
.jpeg?auto=format&fit=max&w=3840)
The lab-leak hypothesis for COVID-19 is becoming a conspiracy theory
To explain where SARS-CoV-2 came from, look at processes with scientific explanations and precedents
Over-the-counter COVID tests are coming sooner rather than later
Scientists and lawmakers agree that over-the-counter rapid tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel.
A decoy may be the key to developing a vaccine against a deadly bioweapon
New research shows how Venezuelan equine encephalitis virus attaches to cells, paving the way for a vaccine
Immunocompromised people must be a priority in the COVID-19 vaccination effort
Vaccinating immunocompromised people will both protect their health and slow viral evolution
Exosomes act as messengers and decoys to save healthy cells from viral infection
New research into how cells battle flu infection could point to new treatments
How should a COVID-19 vaccine be distributed?
With Pfizer and Moderna vaccines proving effective, how should a population get vaccinated?
Could the next coronavirus outbreak come from pigs?
A virus called SADS-CoV could also spillover to humans
What counts as 15 minutes of close contact?
An epidemiologist explains the CDC guidance
Testing for lesser known antibodies produces a better COVID-19 test
Most antibody tests look for responses to SARS-CoV-2's spike protein, but more accurate results include antibodies against the virus's other proteins
A grape virus causes vineyards to lose $60,000 per hectare, and there's no defense against it
Red blotch disease alters the chemical composition and taste of critical winemaking grapes
A virus-like COVID-19 vaccine is being grown in tobacco plants
The "virus-like particle" produced by the Canadian company Medicago is the only vaccine in clinical trials made in plants
